Adverse drug reactions causing admission to a paediatric hospital

Ruairi M Gallagher1, Jennifer R Mason, Kim A Bird

  • 1Department of Women's and Children's Health, University of Liverpool, Liverpool, United Kingdom. ruairi.gallagher@nhs.net

Plos One
|December 11, 2012
PubMed

Insights

Adverse drug reactions (ADRs) affect nearly 3% of pediatric hospital admissions, with many avoidable. Interventions are needed to reduce the burden of ADRs in children.

Area of Science:

  • Pediatric pharmacology
  • Public health
  • Clinical toxicology

Background:

  • Adverse drug reactions (ADRs) pose a significant public health challenge, particularly in vulnerable pediatric populations.
  • Understanding the incidence and causes of ADRs is crucial for developing effective prevention strategies.

Purpose of the Study:

  • To determine the incidence of ADRs in children admitted to a tertiary pediatric hospital.
  • To identify specific drugs and prescribing patterns associated with ADRs.
  • To assess the avoidability of ADRs and inform potential interventions.

Main Methods:

  • Prospective observational study conducted over one year at a UK tertiary children's hospital.
  • Included all acute pediatric admissions, analyzing medication use in the two weeks prior to admission.
  • Outcome measure was the occurrence of an adverse drug reaction.

Main Results:

  • An estimated 2.9% of acute pediatric admissions were related to ADRs, with 97.1% contributing to the admission.
  • Approximately 22.1% of ADRs were deemed avoidable, with most originating from hospital prescribing.
  • Commonly implicated drugs included cytotoxic agents, corticosteroids, NSAIDs, vaccines, and immunosuppressants, leading to neutropenia, immunosuppression, and thrombocytopenia.

Conclusions:

  • ADRs represent a substantial public health issue in pediatric hospital admissions.
  • A significant proportion of ADRs requiring hospitalization are potentially avoidable, highlighting the need for improved prescribing practices.
  • Targeted interventions focusing on hospital-based prescribing are necessary to mitigate the impact of ADRs in children.
Abstract

Related Concept Videos

Pharmaceutical Poisoning: Potential Scenarios01:26

Pharmaceutical Poisoning: Potential Scenarios

Pharmaceutical poisoning can occur through various channels, impacting an estimated 2 million hospitalized patients in the U.S. annually with serious adverse drug responses. These scenarios encompass both therapeutic uses, such as drug toxicity, where even standard dosages can lead to severe central nervous system depression, and non-therapeutic exposures, including accidental ingestion by children, and environmental and occupational exposures.Unintentional poisonings often involve exploratory...
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
Drug Toxicity: Risk factors01:24

Drug Toxicity: Risk factors

Adverse Drug Reactions (ADRs) are potential complications that arise during pharmacotherapy, influenced by multiple risk factors. Age plays a significant role; both neonates and the elderly are at heightened risk due to their respective immature and diminished metabolic and elimination processes. Gender also impacts ADRs, with females experiencing a 1.5 to 1.7-fold greater risk than males, which may be linked to pharmacokinetic, pharmacodynamic, and hormonal differences. Notably, neonates, the...
Drug Toxicity: Overview01:00

Drug Toxicity: Overview

Drug toxicity quantifies the harm a compound causes to an organism, varying by dose and potentially impacting whole systems or specific organs like the liver. Toxic reactions may arise from venomous insect or spider bites, with effects ranging from mild symptoms to severe outcomes such as brain damage or death. Common forms of acute poisoning include ethanol intoxication and overdose of pain or fever medications, with substances like GHB and heroin being particularly lethal at doses close to...
Pharmacovigilance01:19

Pharmacovigilance

Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight, compared...